Optimism and caution for an inactivated COVID-19 vaccine
- PMID: 33485467
- PMCID: PMC7825871
- DOI: 10.1016/S1473-3099(20)30988-9
Optimism and caution for an inactivated COVID-19 vaccine
Comment on
-
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial.Lancet Infect Dis. 2021 May;21(5):637-646. doi: 10.1016/S1473-3099(20)30942-7. Epub 2021 Jan 21. Lancet Infect Dis. 2021. PMID: 33485468 Free PMC article. Clinical Trial.
References
-
- Voysey M, Clemens SAC, Madhi SA, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2020 doi: 10.1016/S0140-6736(20)32661-1. published online Dec 8. - DOI - PMC - PubMed
-
- McDonnell A, Van Exan R, Lloyd S, et al. Center for Global Development; Washington, DC: October, 2020. COVID-19 Vaccine predictions: using mathematical modelling and expert opinions to estimate timelines and probabilities of success of COVID-19 vaccines.https://www.cgdev.org/publication/covid-19-vaccine-predictions
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical